Finally, the precise role of identified hub genes in AD requires additional elucidation both in vitro and in vivo. Further research is essential to determine whether CCR7, CXCL10, IRF7, MMP1, and RRM2 could be used as predictive biomarkers for the diagnosis and treatment of AD. The gene discussed is MMP1; the disease is Alzheimer disease.